openPR Logo
Press release

Global NMDA Receptor Antagonist Market Research Report 2023 to 2028

06-25-2023 10:05 AM CET | Health & Medicine

Press release from: Valuates Reports

Global NMDA Receptor Antagonist Market Research Report 2023

The global NMDA Receptor Antagonist market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2028.

NMDA receptor antagonists are a class of drugs that block the activity of the N-methyl-D-aspartate (NMDA) receptor, which is involved in excitatory neurotransmission in the brain. While NMDA receptor antagonists have primarily been studied and used in conditions like depression and schizophrenia, there is emerging research exploring their potential in Parkinson's disease and Alzheimer's disease. However, it's important to note that the use of NMDA receptor antagonists in these conditions is still investigational, and no specific drugs in this class have been approved for the treatment of Parkinson's disease or Alzheimer's disease.

In Parkinson's disease, research suggests that NMDA receptor antagonists may have neuroprotective effects and potentially reduce the motor symptoms associated with the condition. The excessive activation of NMDA receptors can lead to an influx of calcium ions and subsequent neuronal damage, which is believed to contribute to the progression of Parkinson's disease. By blocking NMDA receptors, antagonists may help regulate the calcium influx and provide neuroprotection. However, more research is needed to determine the effectiveness and safety of NMDA receptor antagonists in Parkinson's disease.

In Alzheimer's disease, the role of NMDA receptor antagonists is more complex. Alzheimer's disease involves the accumulation of beta-amyloid plaques and the formation of neurofibrillary tangles, which lead to neuronal dysfunction and cognitive decline. NMDA receptor antagonists may help by modulating glutamate activity, as excessive glutamate release can be toxic to neurons and contribute to neurodegeneration. By blocking NMDA receptors, antagonists can potentially reduce the excitotoxicity associated with Alzheimer's disease. However, clinical trials investigating NMDA receptor antagonists in Alzheimer's disease have shown mixed results, and more research is necessary to determine their efficacy.

It's important to recognize that the treatment of Parkinson's disease and Alzheimer's disease is complex and multifaceted. Current standard therapies involve a combination of medications, rehabilitation strategies, and supportive care.

Market Share Analysis

The North American market for NMDA Receptor Antagonist is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

Asia-Pacific market for NMDA Receptor Antagonist is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2022 through 2028.

The major global manufacturers of NMDA Receptor Antagonist include Algernon Pharmaceuticals, Relmada Therapeutics, UCB, Avanir Pharmaceuticals, Axsome Therapeutics, Seelos Therapeutics, PharmaTher, Cessatech and ATAI Life Sciences, etc. In 2021, the world's top three vendors accounted for approximately % of the revenue.

View full Report
https://reports.valuates.com/market-reports/QYRE-Auto-26P12399/global-nmda-receptor-antagonist

NMDA Receptor Antagonist segment by Type
• Vaccine
• Monoclonal Antibody
• Application Insights

NMDA Receptor Antagonist segment by Application
• Parkinson's Disease
• Alzheimer's Disease
• Others

BY REGION
• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Get Free Sample:
https://reports.valuates.com/request/sample/QYRE-Auto-26P12399/Global_NMDA_Receptor_Antagonist_Market_Research_Report_2022

Similar Report

https://reports.valuates.com/market-reports/QYRE-Auto-3X6204/global-dextromethorphan

https://reports.valuates.com/market-reports/QYRE-Auto-0L14683/global-memantine-hcl-api

https://reports.valuates.com/market-reports/QYRE-Auto-34V12824/global-alzheimer-s-treatment-drugs

https://reports.valuates.com/reports/QYRE-Auto-29S2943/global-orphan-drugs

Valuates Reports
sales@valuates.com
For U.S. Toll-Free Call 1-(315)-215-3225
For IST Call +91-8040957137
WhatsApp: +91-9945648335
Website: https://reports.valuates.com
Twitter - https://twitter.com/valuatesreports

Valuates offers in-depth market insights into various industries. Our extensive report repository is constantly updated to meet your changing industry analysis needs.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global NMDA Receptor Antagonist Market Research Report 2023 to 2028 here

News-ID: 3101631 • Views:

More Releases from Valuates Reports

AI-Powered Pathology Market Size, Revenue Share, Insights & Future Outlook
AI-Powered Pathology Market Size The global market for AI-Powered Pathology was valued at US$ 184 million in the year 2023 and is projected to reach a revised size of US$ 382 million by 2030, growing at a CAGR of 11.7% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-33C18563/Global_AI_Powered_Pathology_Market_Research_Report_2024?utm_source=openpr&utm_medium=referral By Type • Automated Image Analysis • Disease Classification • Predictive Modeling By Application • Hospital • Diagnostic Centers • Laboratories & Research Institutes Key Companies Indica Labs, Aignostics, Deep Bio, Mindpeak, Paige AI, DoMore Diagnostics, Visiopharm, Sonrai Analytics, Stratipath,
AI In Clinical Trials Market Size, Revenue Share, Insights & Future Outlook
AI In Clinical Trials Market Size The global market for AI In Clinical Trials was valued at US$ 52.3 million in the year 2024 and is projected to reach a revised size of US$ 82.4 million by 2031, growing at a CAGR of 6.8% during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-29K15279/Global_AI_In_Clinical_Trials_Market_Research_Report_2023?utm_source=openpr&utm_medium=referral By Type • Software • Service By Application • Pharmaceutical and Biotechnology Companies • Contract Research Organization Key Companies Intel, The International Business Machines Corporation(IBM), Koninklijke Philips N.V., ConcertAl, Saama Technologies LLC,
Forensic Accounting Services Market Size, Revenue Share, Insights & Future Outlo …
Forensic Accounting Services Market The global Forensic Accounting Services market was valued at US$ 19930 million in 2022 and is anticipated to reach US$ 31160 million by 2029, witnessing a CAGR of 7.7% during the forecast period 2023-2029. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-1E9323/Global_Forensic_Accounting_Services_Market_Size_Status_and_Forecast_2022?utm_source=openpr&utm_medium=referral In general, forensic accounting services entail using the specialized expertise and investigative abilities that CPAs possess to gather, examine, and assess the evidence as well as to interpret and convey conclusions
Dental Anesthesia Market Size, Revenue Share, Insights & Future Outlook
Dental Anesthesia Market The global market for Dental Anesthesia was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-8V13175/Global_Dental_Anesthesia_Market_Research_Report_2023?utm_source=Openpr&utm_medium=Referral By Type • Articaine • Lidocaine • Mepivacaine • Bupivacaine • Prilocaine • Others By Application • Carpool/Cartridges • Ampoules • Vials Key Companies Laboratorios Inibsa, Pierre Pharma, Septodont, Laboratorios Normon, Primex Pharmaceuticals, ASPEN Group, 3M Company, Dentsply, Fresenius-Kabi The Dental Anesthesia Market is experiencing steady market growth as dental care

All 5 Releases


More Releases for NMDA

Rapid-acting Antidepressants (NMDA receptor modulators) Market Size, Clinical Tr …
Rapid-acting Antidepressants (NMDA receptor modulators) Market Size is estimated to be $3560 million in 2024 and is expected to grow at an average yearly rate of around 8% during the timeframe (2025-2032). What is Rapid-acting Antidepressants (NMDA receptor modulators) and what are the growth drivers of Rapid-acting Antidepressants (NMDA receptor modulators) Market? Rapid-acting antidepressants (RAADs) are a class of novel therapeutics designed to alleviate symptoms of depression within hours or
Significant Investment Secured to Advance Precision Medicine for Anti-NMDA Recep …
"What Is the Expected Size and Growth Rate of the Encephalitis Treatment Market? The encephalitis treatment market has grown strongly in recent years. It will expand from $21.09 billion in 2024 to $22.38 billion in 2025, at a compound annual growth rate (CAGR) of 6.1%. The growth is driven by the high incidence of encephalitis, the prevalence of viral or bacterial infections, government initiatives, and the rising demand for preventive encephalitis
Significant Investment Secured to Advance Precision Medicine for Anti-NMDA Recep …
What Is the Expected Size and Growth Rate of the Encephalitis Treatment Market? The encephalitis treatment market has grown strongly in recent years. It will expand from $21.09 billion in 2024 to $22.38 billion in 2025, at a compound annual growth rate (CAGR) of 6.1%. The growth is driven by the high incidence of encephalitis, the prevalence of viral or bacterial infections, government initiatives, and the rising demand for preventive encephalitis
Glutamate Receptor Ionotropic NMDA 2B Market to Witness Huge Growth by 2027 Covi …
A huge collection of procedures and actions are documented in this Glutamate Receptor Ionotropic NMDA 2B market analysis to help organization take sound and smart decision. Prioritized information presented here makes the task of understanding latest market scenario with ease. It captures competition level and market size for the projected years 2021-2027. It focuses on market segmentation according to region, type and end-use. It further aims at gathering important data
Neuroprotective Products Market Is Expected To Grow At A Rapid Pace Throughout B …
Acumen Research and Consulting has announced the addition of the "Neuroprotective Products Market” report to their offering. The Neuroprotective Products Market Report 2018 is an in depth study analyzing the current state of the Neuroprotective Products Market. It provides brief overview of the market focusing on definitions, market segmentation, end-use applications and industry chain analysis. The study on Neuroprotective Products Market provides analysis of China market covering the industry trends, recent
Anti-Suicide Drugs Market Report 2018: Segmentation by Chemistry Type (Anti-Depr …
Global Anti-Suicide Drugs market research report provides company profile for Pfizer, Inc., AstraZeneca plc, Eli Lilly and Company, Allergan plc, GlaxoSmithKline plc, Merck & Co., Inc., H. Lundbeck A/S, NeuroRx, Inc., Johnson & Johnson and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate,